Dosage and Administration For treatment of postmenopausal symptoms and symptoms of estrogen deficiency due to surgical menopause, and for prevention of postmenopausal osteoporosis in women with an intact uterus, transdermal estradiol 0.05 mg/day is recommended for the first 14 days of a 28-day cycle,...
Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report. Contraception. 1983;28:1–20.Toppozada HK, Koetsawang S, Aimakhu VE, Khan T, Pretnar-Darovec A, Chatterjee TK, ...
Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report. WHO special programme of research, development and research training in human reproduction. Contraception 1983;28:1-20....